Similar Articles
41 Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus
42 Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapy
43 Hepatocellular carcinoma in patients without cirrhosis
44 Comparative efficacy of hyperbaric bupivacaine vs hyperbaric ropivacaine in spinal anesthesia for cesarean section: A meta-analysis
45 Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
46 Risk of hepatocellular carcinoma according to body mass index and waist circumference in nonalcoholic fatty liver disease
47 Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis
48 Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma
49 Global scientific trends on hepatocellular carcinoma research from 2004 to 2023: A bibliometric and visualized analysis
50 Preoperative model for predicting early recurrence in hepatocellular carcinoma patients using radiomics and deep learning: A multicenter study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA